loading

Cosciens Biopharma Inc Aktie (CSCI) Neueste Nachrichten

pulisher
Dec 16, 2025

(CSCI) Trading Advice (CSCI:CA) - news.stocktradersdaily.com

Dec 16, 2025
pulisher
Dec 13, 2025

(CSCI) Technical Pivots with Risk Controls (CSCI:CA) - news.stocktradersdaily.com

Dec 13, 2025
pulisher
Dec 13, 2025

MSN Money - MSN

Dec 13, 2025
pulisher
Dec 07, 2025

(CSCI) Strategic Investment Guide (CSCI:CA) - news.stocktradersdaily.com

Dec 07, 2025
pulisher
Dec 04, 2025

Long Term Trading Analysis for (CSCI) (CSCI:CA) - news.stocktradersdaily.com

Dec 04, 2025
pulisher
Dec 04, 2025

Is COSCIENS Biopharma Inc. stock a safe haven assetQuarterly Portfolio Report & Daily Volume Surge Signals - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Why analysts upgrade COSCIENS Biopharma Inc. stockEarnings Summary Report & Entry Point Confirmation Alerts - Newser

Dec 04, 2025
pulisher
Dec 01, 2025

Cosciens Biopharma Brief: Announcing Exclusive Distribution Agreement With Wuzhou Drug International For Macrilen In Hainan-Guangdong-Hong Kong-Macao Greater Bay Area And Singapore - MarketScreener

Dec 01, 2025
pulisher
Dec 01, 2025

COSCIENS Biopharma Secures Exclusive Distribution Deal for Macrilen® in Asia - TipRanks

Dec 01, 2025
pulisher
Dec 01, 2025

COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen® in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore - The Manila Times

Dec 01, 2025
pulisher
Dec 01, 2025

COSCIENS (TSX: CSCI) gives Wuzhou Macrilen rights, ten-year term, €800,000 order - Stock Titan

Dec 01, 2025
pulisher
Nov 27, 2025

How COSCIENS Biopharma Inc. stock performs in rate cut cycles2025 Top Gainers & Capital Efficient Trading Techniques - moha.gov.vn

Nov 27, 2025
pulisher
Nov 23, 2025

Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week - MSN

Nov 23, 2025
pulisher
Nov 23, 2025

(CSCI) Strategic Equity Report (CSCI:CA) - news.stocktradersdaily.com

Nov 23, 2025
pulisher
Nov 20, 2025

Tools to assess COSCIENS Biopharma Inc.’s risk profileAnalyst Downgrade & Long Hold Capital Preservation Tips - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Is COSCIENS Biopharma Inc. stock a safe investment in uncertain marketsWall Street Watch & Low Drawdown Investment Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can COSCIENS Biopharma Inc. stock deliver surprise earnings beat2025 Market Overview & Free Accurate Trade Setup Notifications - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Chart overlay techniques for tracking COSCIENS Biopharma Inc.Earnings Recap Summary & Smart Money Movement Alerts - newser.com

Nov 19, 2025
pulisher
Nov 17, 2025

(CSCI) Dynamic Trading Report (CSCI:CA) - news.stocktradersdaily.com

Nov 17, 2025
pulisher
Nov 17, 2025

COSCIENS Biopharma Appoints Peter H. Puccetti as Interim CEO - MarketScreener

Nov 17, 2025
pulisher
Nov 16, 2025

COSCIENS Biopharma Names Puccetti Interim CEO After Biehn Resigns - 富途牛牛

Nov 16, 2025
pulisher
Nov 15, 2025

How currency fluctuations impact COSCIENS Biopharma Inc. stockQuarterly Trade Summary & Low Drawdown Trading Strategies - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Will COSCIENS Biopharma Inc. stock see insider buyingExit Point & Weekly Watchlist for Hot Stocks - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

COSCIENS Biopharma appoints interim CEO - MSN

Nov 15, 2025
pulisher
Nov 15, 2025

COSCIENS Biopharma Appoints New Interim CEO Amid Strategic Shifts - The Globe and Mail

Nov 15, 2025
pulisher
Nov 14, 2025

COSCIENS Biopharma Inc. Announces Leadership Change - Lelezard

Nov 14, 2025
pulisher
Nov 14, 2025

Cosciens Biopharma announces leadership change - MarketScreener

Nov 14, 2025
pulisher
Nov 14, 2025

Live market analysis of COSCIENS Biopharma Inc.Dividend Hike & Growth Oriented Trading Recommendations - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

COSCIENS Biopharma (TSX: CSCI) appoints Peter Puccetti interim CEO, succeeding Anna Biehn - Stock Titan

Nov 14, 2025
$38.43
price up icon 0.31%
$97.31
price down icon 0.33%
$31.50
price down icon 0.66%
$91.46
price down icon 0.15%
biotechnology ONC
$307.02
price up icon 0.32%
$166.55
price down icon 16.08%
Kapitalisierung:     |  Volumen (24h):